Results

15 records – page 1 of 1.

A Public Health Perspective on Cannabis and Other Illegal Drugs : CMA Submission to the Special Senate Committee on Illegal Drugs

https://policybase.cma.ca/en/permalink/policy1968

Last Reviewed
2020-02-29
Date
2002-03-11
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
on Cannabis and Other Illegal Drugs CMA Submission t Committee on Illeg March 11, 2002 HENRY HADDAD, MD
  2 documents  
Policy Type
Parliamentary submission
Last Reviewed
2020-02-29
Date
2002-03-11
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Documents

Less detail

CMA Letter to the Senate Committee on Legal and Constitutional Affairs regarding Bill C-2, An Act to amend the Criminal Code and to make consequential amendments to other Acts

https://policybase.cma.ca/en/permalink/policy9110

Last Reviewed
2020-02-29
Date
2008-02-19
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
groups. Published reports indicate that the prevalence of driving under the influence of cannabis
  1 document  

Authorizing Cannabis for Medical Purposes

https://policybase.cma.ca/en/permalink/policy11514

Last Reviewed
2020-02-29
Date
2015-02-28
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
POLICY Authorizing Cannabis for Medical Purposes The legalization of cannabis for recreational
  1 document  
Policy Type
Policy document
Last Reviewed
2020-02-29
Date
2015-02-28
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Documents

Less detail

Health Canada consultation on potential market for cannabis health products that would not require practitioner oversight

https://policybase.cma.ca/en/permalink/policy14125

Date
2019-09-03
Topics
Health care and patient safety
Population health/ health equity/ public health
response: HEALTH CANADA CONSULTATION ON POTENTIAL MARKET FOR CANNABIS HEALTH PRODUCTS THAT WOULD
  1 document  

Cannabis for Medical Purposes

https://policybase.cma.ca/en/permalink/policy10045

Last Reviewed
2019-03-03
Date
2010-12-04
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
POLICY Cannabis for Medical Purposes CMA Position: The Canadian Medical Association (CMA) has
  1 document  
Policy Type
Policy document
Last Reviewed
2019-03-03
Date
2010-12-04
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Documents

Less detail

Health Canada consultation on Canadian drugs and substances strategy

https://policybase.cma.ca/en/permalink/policy14017

Date
2018-12-04
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Population health/ health equity/ public health
public health policy approach. Changes to the criminal law affecting cannabis must not promote
  1 document  

Bill C-45: The Cannabis Act

https://policybase.cma.ca/en/permalink/policy13861

Date
2018-04-18
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
CMA Submission: Bill C-45: The Cannabis
  1 document  

CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/en/permalink/policy13918

Date
2018-02-15
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Health care and patient safety
of flavours in vaping products that may appeal to youth, such as soft drinks and cannabis, to be a positive
  1 document  

Proposed approach to the regulation of cannabis

https://policybase.cma.ca/en/permalink/policy13838

Date
2018-01-19
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
submission: PROPOSED APPROACH TO THE REGULATION OF CANNABIS Submission to Health Canada January 19
  1 document  

Excise duty framework for cannabis products

https://policybase.cma.ca/en/permalink/policy13799

Date
2017-12-07
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Framework for Cannabis Products Submission to the Government of Canada consultation on the proposed
  1 document  

Bill C-45: The Cannabis Act

https://policybase.cma.ca/en/permalink/policy13723

Date
2017-08-18
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
CMA Submission: Bill C-45: The Cannabis Act Submission to the House of Commons
  1 document  

Canada’s lower-risk cannabis use guidelines (LRCUG)

https://policybase.cma.ca/en/permalink/policy13726

Date
2017-05-26
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Canada’s Lower-Risk Cannabis Use Guidelines (LRCUG) Recommendations • Cannabis use has
  1 document  

CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/en/permalink/policy13641

Date
2017-04-07
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
to youth, such as soft drinks and cannabis, to be a positive step. A recent report published
  1 document  

Legalization, regulation and restriction of access to marijuana

https://policybase.cma.ca/en/permalink/policy11954

Date
2016-08-29
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
drugs and/or alcohol. Harm reduction measures, such as those outlined in the Lower Risk Cannabis
  2 documents  

The Health risks and harms associated with the use of marijuana

https://policybase.cma.ca/en/permalink/policy11138

Date
2014-05-27
Topics
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
with the use of marijuana. Marijuana, or cannabis, is a Schedule II drug under the Canadian Controlled Drugs
  1 document  

15 records – page 1 of 1.